Maximum quantity allowed is 999
请选择数量
CAS RN: 152459-95-5 | 產品號碼: I0906
| 產品號碼 | I0906 |
純度/分析方法 
|
>98.0%(HPLC) |
| 分子式 / 分子量 | C__2__9H__3__1N__7O = 493.62 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Frozen (<0°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Air Sensitive,Heat Sensitive |
| 包裝和容器
|
100MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 152459-95-5 |
| 相關CAS RN
|
220127-57-1 |
| Reaxys-RN | 9300263 |
| PubChem Substance ID | 253661909 |
| Merck Index(14) | 4902 |
| MDL編號 | MFCD05662257 |
產品規格
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 97.0 % |
| Melting point | 207.0 to 211.0 °C |
性質
| 熔點 | 209 °C |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P405 : Store locked up. |
相關法規
| RTECS # | CV5585673 |
運輸資料
| HS編碼* | 2933.59-000 |
Application
Imatinib: A Tyrosine Kinase Inhibitor and a Molecular-Targeted Agent
Imatinib is a synthetic tyrosine (Tyr) kinase inhibitor and a molecular-targeted agent that specifically target several protein tyrosine kinases, such as stem-cell factor receptor (c-KIT), platelet-derived growth factor receptor (PDGF-R), and notably Bcr-Abl. Imatinib mesylate [I0936] is used in the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies. (The product is for research purpose only.)
References
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug (a review)
- Mechanisms and implications of imatinib resistance mutations in BCR-ABL (a review)
- The development of imatinib as a therapeutic agent for chronic myeloid leukemia
- Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukemia
考研文獻
文檔
產品介紹報導
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。